ERIC WOLFSON: Open Payments
NPI 1023044773 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,749 in 93 payments from 25 companies in 2025. Trend: 2023 $1,739 · 2024 $1,620 · 2025 $1,749
Food & beverage: $1,707Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $420 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $217 |
| Novo Nordisk Inc | 13 | $208 |
| ABBVIE INC. | 14 | $142 |
| Mannkind Corporation | 4 | $98 |
| Exact Sciences Corporation | 6 | $91 |
| Lilly USA, LLC | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Abbott Laboratories | 2 | $47 |
| SHIELD THERAPEUTICS INC | 2 | $40 |
Products named: AIRSUPRA, CAPLYTA, AFREZZA, Wegovy, FARXIGA, VRAYLAR, Cologuard Collection Kit, Kerendia.
Industry payments across NV — which companies pay providers there.
